HONG KONG, March 20, 2015 /PRNewswire/ - Dragon Jade International Limited (OTC:DGJI) is very pleased to announce that Dr. Richard J. Ko has been appointed as a Medical Advisor to the Board of Directors for the Company.
Dr. Ko will serve in a medical advisory role to the Company as the Company provides clinical research consulting services to dietary supplement and herbal product manufacturers who plan to submit their new treatments to U.S. Food and Drug Administration (FDA) or drug regulatory authorities of other countries for approval, and to achieve legal sale status of their products.
Dr. Ko's areas of specialization include Pharmacokinetics, Drug Metabolism, Analytical Chemistry (High Performance Liquid Chromatography and Gas Chromatography) in pharmaceutical and herbal products, and global regulatory requirements on dietary supplements, herbal products and drugs with special emphasis of the United States, China and European Union requirements.
Dr. Ko has been a Registered Pharmacist in California and Nevada since 1986. Dr. Ko also served as Clinical In-Patient Pharmacist of Estelle Doheny Eye Hospital in Los Angeles from 1986 to 1991. He also served as Research Scientist IV (Food and Drug Scientist) and Commission Officer of the U.S. Food and Drug Administration of the State of California from 1991 to 2007. Dr. Ko, in addition, served as Clinical In-Patient Pharmacist of Sutter Memorial Hospital in Sacramento from 1991 to 1992 and as Clinical In-Patient Pharmacist of Vencor Hospital-Sacramento in Folsom from 1993 to 1994.
Prior to joining the Company, Dr. Ko served as Chair of the United States Pharmacopeia Beta-Alanine Expert Panel from 2011 to 2012. Prior to that, he served as a Member of the United States Pharmacopeia, Dietary Supplements - Information Expert Committee from 2005 to 2010. He also served as a Commission Officer of U.S. Food and Drug Administration from 1991 to 2007 and as a Commission Officer of U.S. Consumer Product Safety Commission from 2002 to 2007. He is currently a Member of the United States Pharmacopeia, Monographs - Dietary Supplements Expert Committee, a Member of the United States Pharmacopeia Metal Impurities Expert Panel and a Member of the Advisory Board of the United States Pharmacopeia Dietary Supplements Compendium.
Dr. Ko graduated with a bachelor's degree in A.B. Biochemistry from the University of California, Berkeley in 1982, a bachelor's degree in Pharmacy from the School of Pharmacy of University of Southern California in 1986, and a Ph.D. from the School of Pharmacy of University of Southern California in 1991. Dr. Ko is the author of many scientific publications and has received several prestigious scholarships and awards, including the USC Faculty Scholarship Award, the USC Graduate Student Fellowship Award, and the Superior Achievement Award of Department of Health Services of California.
"Dr. Ko's deep knowledge of and experiences in drug and food regulatory affairs brings a unique expertise to the Company," remarked Dr. Yat Man Lai, CEO of the Company. "This is a big business opportunity for the Company with Dr. Ko's expertise since a large number of herbal supplement manufacturers have expressed interest to bring their treatments to pass through internationally recognized clinical trials with our professional assistance and then to also have us represent their marketing and distribution interests for their treatments."
About Dragon Jade
Dragon Jade International Limited and its subsidiaries ("the Group") focused on identifying, developing and marketing the next generation of herbal and natural products that improve people's lives. The Group is positioned to leverage proven resources that allow us to assess, enhance and realize the commercial potential of herbal and biotechnological discoveries. The Group strives to develop and offer to the market the broadest selection of cost-effective healthy living products, which shall deliver substantial returns to investors. More information on Dragon Jade, visit the Company's website: www.dgjigroup.com.
Safe Harbor Statement
This release includes forward-looking statements. These forward-looking statements generally can be identified by phrases such as the Company "believes," "expects," "anticipates," "foresees," "estimates" or other words or phrases of similar import. Similarly, statements herein that describe the Company's business strategy, outlook, objectives, plans, intentions or goals also are forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements.
SOURCE Dragon Jade International Limited
Copyright © 2015 PR Newswire. All Rights Reserved